These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16980024

  • 1. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
    Wang SS, Chou NK, Chi NH, Hsu RB, Huang SC, Chen YS, Yu HY, Tsao CI, Ko WJ, Lai MY, Chu SH.
    Transplant Proc; 2006 Sep; 38(7):2138-40. PubMed ID: 16980024
    [Abstract] [Full Text] [Related]

  • 2. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH.
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [Abstract] [Full Text] [Related]

  • 3. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 4. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 5. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA, Buffello-Le Guillou D, Roche B, Dussaix E, Duclos-Vallée JC, Féray C, Samuel D.
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z, Zemel R, Kazetsker A, Fraser G, Tur-Kaspa R.
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [Abstract] [Full Text] [Related]

  • 7. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY, Huh W, Lee DH, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [Abstract] [Full Text] [Related]

  • 8. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
    Kim JA, Huh W, Lee KW, Kim SJ, Kim YG, Kim DJ, Joh JW, Oh HY.
    Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352
    [Abstract] [Full Text] [Related]

  • 9. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    Shitrit AB, Kramer MR, Bakal I, Morali G, Ben Ari Z, Shitrit D.
    Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
    [Abstract] [Full Text] [Related]

  • 10. Heart transplantation using donors positive for hepatitis.
    Wang SS, Chou NK, Ko WJ, Yu HY, Chen YS, Hsu RB, Huang SC, Chi NH, Tsao CI, Lai MY, Liau CS, Lee YT.
    Transplant Proc; 2004 Oct; 36(8):2371-3. PubMed ID: 15561252
    [Abstract] [Full Text] [Related]

  • 11. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK.
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [Abstract] [Full Text] [Related]

  • 12. Changes in serological markers of hepatitis B virus after renal transplantation.
    Urbini Dos Santos C, Sevá-Pereira T, Alves-Filho G, Lorena SL, Soares EC, Mazzali M.
    Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
    [Abstract] [Full Text] [Related]

  • 13. Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.
    Filik L, Karakayali H, Moray G, Dalgiç A, Emiroğlu R, Ozdemir N, Colak T, Gür G, Yilmaz U, Haberal M.
    Transplant Proc; 2006 Mar; 38(2):496-8. PubMed ID: 16549158
    [Abstract] [Full Text] [Related]

  • 14. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D, Rayes N, Steinmüller T, Müller AR, Settmacher U, Neuhaus R, Radke C, Berg T, Hopf U, Neuhaus P.
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [Abstract] [Full Text] [Related]

  • 15. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A, Boehm S, Hahn J, Holler E, Jilg W.
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [Abstract] [Full Text] [Related]

  • 16. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y, Yang Y, Zhang J, Yi HM, Lu MQ, Cai CJ, Li X, Jiang N, Xu C, Li H, Wang GS, Yi SH, Zhang JF, Jiang H, Yang Q, Chen GH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [Abstract] [Full Text] [Related]

  • 17. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 18. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H.
    Clin Transplant; 2006 Feb; 20(3):351-8. PubMed ID: 16824154
    [Abstract] [Full Text] [Related]

  • 19. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
    Hann HW, Fontana RJ, Wright T, Everson G, Baker A, Schiff ER, Riely C, Anschuetz G, Gardner SD, Brown N, Griffiths D, United States Lamivudine Compassionate Use Study Group.
    Liver Transpl; 2003 Jan; 9(1):49-56. PubMed ID: 12514773
    [Abstract] [Full Text] [Related]

  • 20. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
    Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, Schiff E, Gish R, Villeneuve JP, Farr G, Anschuetz G, Crowther L, Brown N.
    Hepatology; 1999 May; 29(5):1581-6. PubMed ID: 10216146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.